Yanagida S, Ohsuzu F, Sakata N, Maie S, Akanuma M, Takayama E, Hayashi K, Aosaki N, Nakamura H
Department of Medicine I, National Defense Medical College, Tokorozawa, Japan.
Jpn Heart J. 1994 Jul;35(4):455-65. doi: 10.1536/ihj.35.455.
Isolated rat hearts were subjected to retrograde perfusion to investigate the protective effects of adenosine and verapamil on the myocardium. In group 1, the perfusate was standard Krebs-Henseleit buffer solution. The perfusate was changed to Krebs-Henseleit buffer containing verapamil (100 nM) in group 2, adenosine (100 microM) in group 3 and both drugs in combination in group 4 for 30 min before ischemia and during 20 min of reperfusion. Group 2 displayed a recovery of creatine phosphate but not of ATP at the end of reperfusion. In group 4, the recovery of both ATP and creatine phosphate was significantly greater than in group 1. The coronary flow of group 4 was significantly higher than that of the other groups. Treatment with both verapamil and adenosine before and after global ischemia may protect the ischemic myocardium by improving high energy phosphate metabolism and coronary circulation.
采用离体大鼠心脏逆行灌注法,研究腺苷和维拉帕米对心肌的保护作用。第1组灌注液为标准的克雷布斯 - 亨塞尔特缓冲液。第2组在缺血前30分钟及再灌注20分钟期间,将灌注液换为含维拉帕米(100 nM)的克雷布斯 - 亨塞尔特缓冲液;第3组换为含腺苷(100 μM)的缓冲液;第4组换为含两种药物的混合液。再灌注结束时,第2组磷酸肌酸有所恢复,但三磷酸腺苷(ATP)未恢复。第4组ATP和磷酸肌酸的恢复均显著高于第1组。第4组的冠脉血流量显著高于其他组。在全心缺血前后给予维拉帕米和腺苷治疗,可能通过改善高能磷酸代谢和冠脉循环来保护缺血心肌。